The Japanese unit of Novartis AG apologized on Thursday for failing to report to authorities in a timely manner side-effects of its leukemia drugs, in the company's latest scandal in the country. Novartis Pharma KK, the Swiss drugmaker's wholly owned local subsidiary, said Japan's Ministry of Health, Labour and Welfare ordered the company to improve its practices after the company did not report side-effects of its Gleevec and Tasigna leukemia treatments until around April. The ministry said serious side-effects must be reported within a month of discovery. Media reports said such side-effects had been known between April 2013 and January 2014.
via Health News Headlines - Yahoo News http://ift.tt/1nVZn8W
No comments:
Post a Comment